DekaBank Deutsche Girozentrale’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,000
Closed -$604K 1304
2023
Q1
$604K Sell
22,000
-43,500
-66% -$1.15M ﹤0.01% 979
2022
Q4
$1.5M Buy
65,500
+46,500
+245% +$1.29M ﹤0.01% 788
2022
Q3
$656K Buy
+19,000
New +$703K ﹤0.01% 988
2021
Q3
Sell
-23,200
Closed -$1.03M 1415
2021
Q2
$1.03M Buy
+23,200
New +$856K ﹤0.01% 900

Other funds holding PRVA

DekaBank Deutsche Girozentrale's PRVA Position: Q2 2023 in Review

DekaBank Deutsche Girozentrale sold out of Privia Health (PRVA) in Q2 2023, closing a stake of 22,000 shares — an estimated $604K sold.

DekaBank Deutsche Girozentrale first reported a position in PRVA in Q2 2021 and held it in 4 quarters. The position peaked at $1.5M in Q4 2022. 234 funds tracked by Wall St. Rank hold PRVA as of Q2 2023.

  • DekaBank Deutsche Girozentrale reported no remaining Privia Health position as of Q2 2023 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 22,000 Privia Health shares in Q2 2023, an estimated $604K.
  • DekaBank Deutsche Girozentrale first reported a position in Privia Health in Q2 2021 and held it in 4 quarters.
  • DekaBank Deutsche Girozentrale's Privia Health position peaked at $1.5M in Q4 2022.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q2 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2023, filed 25 Jul 2023.